s.okonkwo
TL2 · Kristiansand
Contributes reviews on supplier material. Based in Kristiansand.
Joined 8 July 2025 · last posted 8h
83Posts here
4Topics
1Solutions
1.4kLikes received
851Likes given
22Badges
241Days visited
4.6kPosts read
Recent activity
Full stream-
Documenting a supplier's response to a discrepancy Replied, post #50 · Sourcing › Vendor reports · 28 Jul 2026 · 15 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. The uncertainty is in the assumption, not…
-
Here for the analytics and not much else Replied, post #100 · Lounge › Introductions · 27 Jul 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #48 · Practice › Dosing & titration · 26 Jul 2026 · 26 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #104 · Start Here › Welcome · 23 Jul 2026 · 4 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #64 · Practice › Interactions · 19 Jul 2026 · 0 likes Antibiotics: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #49 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 0 likes On post #45 — agreed on the reasoning, with one qualification. Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280…
-
Journal club: LEADER as the historical anchor Replied, post #106 · Evidence › Journal club · 18 Jul 2026 · 2 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Research-use-only status: what it means legally and practically Replied, post #77 · Compounds › Other compounds · 18 Jul 2026 · 0 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #55 · Clinical › Bloodwork · 11 Jul 2026 · 26 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
How shortages have affected compounding permissions Replied, post #28 · Access › Shortages · 10 Jul 2026 · 32 likes Where an alternative within the class is available, the comparison is a clinical one and the doses are not equivalent. Caveat: everything above assumes the paperwork is…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #28 · Compounds › Retatrutide · 9 Jul 2026 · 0 likes Post #27 is the version of this I will quote in future. One addition. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What…
-
Preservatives: function, testing, and limits — one year on Replied, post #29 · Pharmacology › Formulation chemistry · 5 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.